Come up with a name for your new list and we'll add to it:
Vaxart (merged with Aviragen Therapeutics) raised a round of funding on December 11, 2009. Investors include
Life Science Angels.
Vaxart has developed a vaccine delivery system that greatly enhances the adaptive immune response to orally delivered antigens. The vaccine system provides a key stimulatory signal (double-stranded RN…